Search our Innovation Portfolio

▤ Summary

This enables diagnosis and treatment within one clinic visit, bringing significant clinical advantages of increased treatment compliance and a reduced risk of onward transmission. Patients will benefit from a simplified clinical pathway potentially obviating the need for follow-up appointments. Biovici is developing a proof of concept sensor capable of detecting a drug and or relevant biomarkers. The biosensor uses nanotechnology to provide rapid point of care, non-invasive diagnostic monitoring. The intervention consists of a disposable test strip and hand held readers.

▦ Linked Companies